Novo CEO pressed by Senate to cut costs of obesity, diabetes medications CEO Lars Fruergaard Jørgensen advised lawmakers the corporation would think about new talks with insurers with regard to the record price ranges of Wegovy and copyright when they pledge to keep the medicines on their formularies. Earlier this https://collinronjf.blogdeazar.com/30764579/not-known-facts-about-healthcare-news